Pharma donor

Biopharmacity and nanomedicine expert Moein Moghimi of the University of Copenhagen, Denmark, and colleagues have received the equivalent of about $5.5m from the Danish Council for Strategic Research (DSF). The money is expected to establish The Centre for Pharmaceutical Nanotechnology and Nanotoxicology (CPNN) in the Faculty of Pharmaceutical Sciences beginning April 2009. Promising nanoscale materials are set to have a significant impact on medicine, Moghimi and colleagues hope. The success of the new center will help transform the national and European biotechnology and pharmaceutical industries, he says.